Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IPO
MedTech
Caris Life Sciences ups IPO to raise $494M
The cancer testing company claimed a valuation of about $5.9 billion, while selling 23.5 million shares under the Nasdaq ticker "CAI" at $21 apiece.
Conor Hale
Jun 18, 2025 11:00am
Odyssey abandons IPO plans as 'not in best interests of company'
Jun 10, 2025 7:25am
Caris Life Sciences to go public in $400M Nasdaq IPO
Jun 9, 2025 10:30am
CapsoVision seeks $30M IPO
May 12, 2025 11:00am
Market volatility adds to 'already challenging' year for IPOs
Apr 11, 2025 9:25am
Artificial heart maker Picard Medical plans to go public
Apr 1, 2025 12:30pm
